PA-BENTLEY-SYSTEMS
6.10.2022 22:02:37 CEST | Business Wire | Press release
FUKUI COMPUTER, Inc (Head Office: Sakai City, Fukui Prefecture; President: Tadashi Sugita), the CAD vendor for the construction industry, has entered into a strategic partnership with Bentley Systems (Head Office: Exton, Pennsylvania, USA; CEO: Greg Bentley), the infrastructure engineering software company, to accelerate the adoption of digital workflows in the Japanese construction industry and support the promotion of digital transformation (DX) in the infrastructure field.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20221006005805/en/
In Japan, there are concerns about the increasing shortage of labor in the infrastructure field, which is impacting the ability to take measures to mitigate aging infrastructure. This situation is further aggravated by the intensification and frequent occurrence of natural disasters. To help combat this, FUKUI COMPUTER will leverage the Bentley iTwin platform to augment its cloud-based data sharing service CIMPHONY Plus with 3D/4D visualization, simulation, and digital twin capabilities. The company will launch a digital solution that supports the entire infrastructure lifecycle, spanning project management, design, construction, and maintenance. FUKUI COMPUTER will also launch TREND ROAD Designer for road design, a new 3D application that will leverage Bentley’s OpenRoads Designer, an industry standard for road concept, design, construction, and operations.
By entering into this strategic partnership, FUKUI COMPUTER will provide solutions for digital transformation (DX) in the infrastructure field promoted by the Ministry of Land, Infrastructure, Transport and Tourism (MLIT), leveraging Bentley’s cutting-edge digital technology. The partnership aims to contribute to the improvement of productivity in the construction industry by introducing and utilizing 3D and digital twin solutions in the design, construction, and maintenance management sectors under the i-Construction and BIM/CIM strategy promoted by MLIT.
Carsten Gerke, senior vice president of strategic channels with Bentley Systems, said, “Collaborating with FUKUI COMPUTER benefits all parties. End users will benefit from cutting-edge, world-class digital technology and trusted local expertise. Bentley will address the demanding Japanese infrastructure market and i-Construction regulations through the market leader in Japan, while FUKUI COMPUTER will provide the most innovative digital twin solutions to dramatically improve the construction industry in Japan.”
Tadashi Sugita, president of FUKUI COMPUTER, said, “The strategic partnership with Bentley Systems will allow us to introduce cutting-edge digital technology to the ICT field in the construction industry in Japan. As a software company being trusted by the construction companies who support the infrastructure in local communities, we will strive to contribute to society by providing useful products and valuable support services.”
##
About Bentley Systems
Bentley Systems (Nasdaq: BSY) is the infrastructure engineering software company. We provide innovative software to advance the world’s infrastructure – sustaining both the global economy and environment. Our industry-leading software solutions are used by professionals, and organizations of every size, for the design, construction, and operations of roads and bridges, rail and transit, water and wastewater, public works and utilities, buildings and campuses, mining, and industrial facilities. Our offerings include MicroStation-based applications for modeling and simulation, ProjectWise for project delivery, AssetWise for asset and network performance, Seequent’s leading geo-professional software portfolio, and the iTwin platform for infrastructure digital twins. Bentley Systems employs more than 4,500 colleagues and generates annual revenues of approximately $1 billion in 186 countries.
www.bentley.com
About FUKUI COMPUTER, Inc
FUKUI COMPUTER, Inc develops and sells CAD-related products to surveying companies, civil engineering construction companies, and agencies responsible for public works projects for each phase of infrastructure construction, including surveying, design, construction, and maintenance. We are proud of our industry-leading track record, with approximately 40,000 companies in Japan. In recent years, the government has been promoting “i-Construction”, which aims to increase productivity using ICT. Technologies such as 3D laser scanning, drone survey, and automatic control of construction equipment using GNSS are rapidly becoming popular. We aim to support these new technologies with software to improve productivity in the entire industry.
https://const.fukuicompu.co.jp/
About the Bentley iTwin Platform
The Bentley iTwin platform is an open, scalable cloud platform that enables development teams to build applications that create, visualize, and analyze digital twins of infrastructure assets. Applications built on the Bentley iTwin platform allow users to incorporate engineering data created by diverse design tools into a living digital twin, aligning it with reality modeling and other associated data without disrupting current tools or processes. The platform also enables the visualization and tracking of all changes, including changes in real-world conditions from drones and IoT-connected sensors. The Bentley iTwin platform facilitates solutions to provide actionable insights for decision-makers across the complete asset lifecycle. The Bentley iTwin platform is the foundation for applications ‘powered by iTwin’ and digital twin solutions created by Bentley and its strategic co-venturers, digital integrators, system integrators, independent software vendors, and software developers.
© 2022 Bentley Systems, Incorporated. Bentley, the Bentley logo, AssetWise, iTwin, MicroStation, OpenRoads, OpenRoads Designer, ProjectWise, and Seequent are either registered or unregistered trademarks or service marks of Bentley Systems, Incorporated or one of its direct or indirect wholly owned subsidiaries. All other brands and product names are trademarks of their respective owners.
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20221006005805/en/
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
FPT Named an OpenAI Select Partner6.8.2026 02:00:00 CEST | Press release
Global IT corporation FPT today announced that it has been named an OpenAI Select Partner within the OpenAI Partner Network. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260805503787/en/ FPT Named an OpenAI Select Partner The OpenAI Partner Network is a global program for partners to build, sell, and deliver AI solutions with OpenAI. It brings together partners with deep industry expertise, delivery capabilities, and customer relationships while equipping them with resources, enablement, and support to help enterprises adopt OpenAI frontier models and products and turn them into measurable impact. As an OpenAI Select Partner, FPT will continue working with OpenAI to help organizations build, deploy, and scale AI solutions responsibly and effectively. This work will help organizations get more useful work from every token and stronger performance per dollar with GPT‑5.6, while using ChatGPT Work to turn ambitious goals into
U.S. FDA Approves Takeda’s ORZEYFUL™ (oveporexton), the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 16.8.2026 00:10:00 CEST | Press release
Adults Taking ORZEYFUL Experienced Significant and Meaningful Improvements Across the Full Range of Symptoms of Narcolepsy Type 1 (NT1) in Clinical Trials Compared to Those on Placebo As a First-in-Class Orexin Treatment, ORZEYFUL has the Potential to Redefine NT1 Care Beyond Individual Symptoms Takeda is Advancing U.S. Launch Preparations and Expects to Make ORZEYFUL Available Following Completion of the Drug Enforcement Administration (DEA) Scheduling Process Takeda (TSE:4502/NYSE:TAK) announced that the U.S. Food and Drug Administration (FDA) approved ORZEYFUL™ (oveporexton), an oral orexin receptor 2 (OX2R) agonist, for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults.* The persistent 24-hour nature of NT1 is driven by orexin deficiency and can severely impact people’s lives. As a first-in-class orexin treatment, ORZEYFUL is the only medicine indicated in the U.S. to treat the disease holistically rather than individual symptoms. “The FDA approval of OR
Compass Pathways Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)5.8.2026 22:30:00 CEST | Press release
Compass Pathways plc (Nasdaq: CMPS), a biotechnology company dedicated to unlocking urgently needed new treatment options in mental health care, announced today that Compass granted equity awards under the Compass Pathways plc 2026 Inducement Plan to fourteen newly hired non-executive employees. The equity awards were granted on August 3, 2026 and consisted of options to purchase an aggregate of 139,355 shares and restricted share units or, in the case of employees in the United Kingdom nominal cost options, covering an aggregate of 66,300 shares. The options have an exercise price per share equal to $11.25, the closing price of the Company’s American Depositary Shares on the Nasdaq Global Select Market on the grant date, and will vest over a four-year period with 25% vesting on the first anniversary of the date of the grant and the remaining 75% vesting in equal monthly installments over the three-year period thereafter, subject to each employee’s continued employment. The restricted
Clinilabs Announces Medical Leadership Appointments5.8.2026 16:05:00 CEST | Press release
Bob Dagher, M.D., Named Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., Named Principal Investigator Clinilabs (“Clinilabs LLC”), a global, full-service contract research organization (CRO) specializing in central nervous system (CNS) drug and device development, today announced the appointments of Bob Dagher, M.D., as Chief Medical Officer and Waqar Ahmed Siddiqui, M.D., as Principal Investigator of the Company’s Eatontown, New Jersey Clinical Research Unit (CRU). Dr. Dagher will provide strategic and medical leadership across the organization, while Dr. Siddiqui will lead the execution of research projects at the Company’s CRU. Together, they will support the design, development, and execution of clinical programs for pharmaceutical, biotechnology, and medical device sponsors advancing innovative therapies for psychiatric, neurological, substance use, and rare CNS disorders. “Clinilabs has earned the trust of sponsors by combining deep scientific expertise, medical leadership,
Interactive Brokers Adds Brazilian Futures through Brazil’s B3 Exchange5.8.2026 16:00:00 CEST | Press release
Interactive Brokers (Nasdaq: IBKR), an automated global broker, today announced that eligible clients outside of Brazil can now trade Brazilian futures in addition to equities through the B3 exchange. Interactive Brokers was the first broker to provide international investors with streamlined, low-cost access to B3. Offering Brazilian futures and equities alongside products across more than 170 markets worldwide underscores IBKR’s commitment to broadening global market access and giving clients efficient, cost-effective ways to diversify through a single, unified platform. Access to B3 provides exposure to one of Latin America’s most active and liquid markets, providing long-term growth potential across multiple sectors and another way for investors to pursue emerging market opportunities. "Global investors deserve seamless, low-cost access to the world's most compelling markets, including emerging economies shaping tomorrow's financial landscape," said Milan Galik, Chief Executive Off
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom